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http://dx.doi.org/10.1016/j.ccr.2014.07.022SUMMARYMetastatic dissemination is often initiated by the reactivation of an embryonic development program referred
to as epithelial-mesenchymal transition (EMT). The transcription factor SNAIL promotes EMT and elicits
associated pathological characteristics such as invasion, metastasis, and stemness. To better understand
the posttranslational regulation of SNAIL, we performed a luciferase-based, genome-wide E3 ligase siRNA
library screen and identified SCF-FBXO11 as an important E3 that targets SNAIL for ubiquitylation and degra-
dation. Furthermore, we discovered that SNAIL degradation by FBXO11 is dependent on Ser-11 phosphor-
ylation of SNAIL by protein kinase D1 (PKD1). FBXO11 blocks SNAIL-induced EMT, tumor initiation, and
metastasis in multiple breast cancer models. These findings establish the PKD1-FBXO11-SNAIL axis as a
mechanism of posttranslational regulation of EMT and cancer metastasis.INTRODUCTION
The majority of cancer-related deaths can be attributed to the
spread of cancer cells to distant vital organs (Wan et al., 2013).
Epithelial-mesenchymal transition (EMT), a crucial process in
embryonic development that allows epithelial cells to lose api-
cal-basal polarity and cell-cell contacts while gaining mesen-
chymal phenotypes, is believed to be utilized by cancer cells to
gain mobility and invasiveness during metastasis (Brabletz,
2012; De Craene and Berx, 2013; Nieto, 2011). A hallmark of
EMT is the functional loss of E-cadherin, and additional cellular
changes, such as reduced expression of the epithelial markers
cytokeratin and ZO-1 and the upregulation of the mesenchymal
markers N-cadherin, Vimentin, and Fibronectin, are also ob-
served frequently.
SNAIL protein was among the first transcription factors
discovered to repressCDH1 gene (encoding E-cadherin protein)Significance
SNAIL is one of themost well establishedmaster transcriptiona
ing of the posttranslational regulations of these factors is lacki
screening strategy to identify E3 ligase(s) targeting the SNAI
FBXO11 as a crucial posttranslational regulator that controls t
this regulation is dependent on Ser-11 phosphorylation of SNA
ple analysis established a crucial role of the PKD1-FBXO11-SN
indicated a potential therapeutic value of targeting this pathw
358 Cancer Cell 26, 358–373, September 8, 2014 ª2014 Elsevier Inctranscription and induce EMT (Batlle et al., 2000; Cano et al.,
2000). Recent studies suggest that SNAIL has a much broader
impact on cancer progression. Inmammary epithelial cells, over-
expression of SNAIL induces EMT, coupled with increased tu-
mor-initiating properties (Mani et al., 2008). In melanoma, SNAIL
promotes tumor metastasis by suppressing host immune sur-
veillance (Kudo-Saito et al., 2009). SNAIL also cooperates with
chromatin-modifying enzymes to inhibit fructose-1,6-biphos-
phatase (FBP1) expression, which results in increased glucose
uptake, macromolecule biosynthesis, and maintenance of ATP
production under hypoxic conditions (Dong et al., 2013). Given
the importance of SNAIL in cancer progression, it is not surpris-
ing that many signaling pathways have been implicated in the
regulation of SNAIL gene expression, including transforming
growth factor b (TGF-b), the NOTCH and WNT pathways, reac-
tive oxygen species, and hypoxic stress (reviewed by De Craene
and Berx, 2013). A better understanding of the regulatoryl regulators of EMT. However, a comprehensive understand-
ng. We developed a high-throughput luciferase-based RNAi
L protein for ubiquitylation and degradation. We identified
he stability of the SNAIL protein. We further uncovered that
IL by PKD1. Importantly, functional studies and clinical sam-
AIL axis in regulating breast cancer EMT andmetastasis and
ay.
.
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block EMT and related processes in cancer progression.
Many transcription factors are labile proteins with short
half-lives and are actively degraded through the ubiquitin-
proteosome pathway. Interestingly, in many cases, E3 ligases
recognize and ubiquitylate transcription factor substrates by in-
teracting with their transcriptional activation/repressor domain.
This allows the coupling of the transcriptional activity with the
protein degradation process to prevent hyperactivation of
important transcription factors (Muratani and Tansey, 2003).
For instance, Mdm2 binds to the transactivation domain of
p53, targeting it for ubiquitylation and degradation (Momand
et al., 1992). Likewise, the E3 ligase FBW7 interacts with the
KLF5 transactivation domain for its degradation (Liu et al.,
2010; Zhao et al., 2010). Although prior studies have identified
two E3 ubiquitin ligases, FBXL14 (Ppa in Xenopus) (Lander
et al., 2011) and FBXW1 (also called b-TRCP or BTRC) (Zhou
et al., 2004), responsible for SNAIL ubiquitylation and degrada-
tion, neither of them interacts with the SNAIL/Gfi-1 domain
(SNAG) transcriptional repression domain of SNAIL. This leads
us to suspect that there may be additional critical E3 ligase(s)
that target(s) the SNAIL protein for degradation through interac-
tion with the SNAG domain. Identifying such E3 ligase(s) and the
signaling events regulating SNAIL ubiquitination will provide
possible new windows for therapeutic targeting of SNAIL.
RESULTS
ALuciferase-Based Screening System for SNAIL Protein
Turnover Regulation
To confirm that the SNAIL protein is posttranslationally
controlled by the ubiquitin-proteosome system (UPS) in breast
cancer, we first blocked protein synthesis using cycloheximide
(CHX) and pulse-chased the SNAIL protein in the SUM1315 hu-
man breast cancer cell line. Indeed, SNAIL was degraded rapidly
and became undetectable within 4 hr of CHX treatment (Fig-
ure 1A; Figure S1A available online). Furthermore, treatment of
cells with the proteosomal inhibitor MG132 increased the stable
SNAIL protein level, confirming that SNAIL is degraded through
the UPS (Figure 1A; Figure S1A).
The identification of E3 ligases responsible for the degrada-
tion process of certain protein substrates has traditionally relied
on serendipitous discoveries or candidate gene approaches. To
identify potential E3 ligase(s) responsible for SNAIL degradation
in an unbiased manner, we designed a luciferase-based small
interfering RNA (siRNA) screening strategy that can be easily
adapted in future discovery efforts to identify new E3 ligase-
protein substrate pairs. We fused the SNAIL protein coding
sequence in-frame with the firefly luciferase gene coding
sequence (SNAIL-Luc) to produce the SNAIL-Luciferase fusion
reporter protein (Figure 1B). This reporter allowed us to monitor
the SNAIL protein stable level and its degradation dynamics by
monitoring the luciferase activity. The SUM1315 cell line was
first transduced with a lentiviral vector containing the SNAIL-
Luc fusion gene and subsequently with the Renilla-Luciferase
retrovirus to generate a dual luciferase reporter cell line with
Renilla luciferase (R-Luc) serving as an internal control. This
cell line is denoted as ‘‘SUM-SNAIL-Luc/R-Luc’’ to facilitate
description below (Figure 1B). The SNAIL-Luc fusion proteinCais localized in the nucleus (Figures S1B and S1C) and has
degradation dynamics similar to those of the endogenous
SNAIL protein (Figures 1C and 1D and Figure S1D). In contrast,
the F-Luc protein alone is very stable (Figures S1E and S1F).
The luciferase activity of the SNAIL-Luc fusion protein is also
readily detectable by standard firefly luciferase reporter assay
and correlates with the fusion protein level (Figure 1E). There-
fore, the firefly luciferase activity in this cell line reliably re-
presents the stable level of the SNAIL-Luc protein, whereas
R-Luc activity is used as an internal control for cell number
and viability.
siRNA Library Screening Identified Potential E3 Ligases
Targeting SNAIL Protein for Degradation
We followed the procedures outlined in Figure 1F to identify po-
tential E3 ligase candidates for SNAIL protein. We first knocked
down individual human E3 ligase by pooled siRNA (three siRNAs
per gene) in SUM-SNAIL-Luc/R-Luc cells and looked for E3
ligase genes whose knockdown (KD) resulted in more than a
2-fold increase in luciferase activity of the SNAIL-Luc fusion
protein (Figure 1F). The cell lysates from these positive hits
were immunoblotted for SNAIL-Luc fusion protein to confirm
protein stabilization. Positive E3 ligase hits were then examined
by a second round of siRNA screening to confirm the results. We
then cloned all positive E3 ligase genes and determined whether
they can interact with SNAIL protein by coimmunoprecipitation
assay (co-IP) and reciprocal co-IP for further confirmation.
Only the proteins that interacted with SNAIL were considered
as E3 candidates for SNAIL protein and selected for further func-
tional testing to determine whether they can affect exogenous
and endogenous SNAIL protein degradation.
The E3 siRNA library screening revealed that siRNA-mediated
inhibition of multiple E3 ligase genes increased the level of
SNAIL-Luc protein. Among the 554 known and predicted human
E1, E2, and E3 ligases (Table S1), siRNA knockdown of more
than 100 genes increased the luciferase activity by more than 2
fold (Figure 1G, top panel). This large initial pool of potential
hits may include false positive candidates that do not directly
regulate SNAIL protein stability. Therefore, further validation of
these candidates is needed. Interestingly, in this screening,
knockdown of FBXW1, a previously known E3 ligase for SNAIL
(Zhou et al., 2004), increased the SNAIL-Luc protein level 2.6-
fold, whereas no change was observed after knockdown of
FBXL14, another SNAIL E3 identified in the Xenopus model
(Lander et al., 2011). The cell lysates from these initial positive
hits were then subjected to immunoblotting for SNAIL-Luc fusion
protein (Figures S1G and S1H), for most of which an upregula-
tion of SNAIL-Luc protein was observed. Among them, 21 E3
candidates, when knocked down individually, increased the
SNAIL-Luc protein level at least 6-fold in a luciferase assay or
in immunoblot analyses, the stringent criteria we set for identi-
fying potential candidates (Table S2). A second round of siRNA
screening for these 21 genes was performed, confirming that
21 siRNAs were able to consistently increase the luciferase ac-
tivity and protein stable level (Figure 1G, bottom panels; Fig-
ure S1I). We cloned the cDNA coding sequences of 13 candidate
genes into a lentiviral expression vector with an N-terminal HA
epitope (Figure S1J). The remaining eight genes were not cloned
successfully. To test the interactions between these 13 E3ncer Cell 26, 358–373, September 8, 2014 ª2014 Elsevier Inc. 359
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test the interactions between these E3 candidates with SNAIL.
Only four E3 ligases were able to interact with SNAIL: FBXO11,
SOCS3, SPSB1, and TRIM5 (Figure S1J). This result was first
confirmed by repeating the co-IP experiment for these four E3
ligase proteins using HA antibody (Figure 1H) and then by recip-
rocal IP of the SNAIL-FLAG protein with an anti-FLAG antibody
(Figure 1I). Therefore, we focused on these four E3 genes in
further functional studies.
FBXO11 Is a Bona Fide E3 Ligase Targeting SNAIL
Protein for Ubiquitylation and Degradation
As an initial step in functionally testing these four E3 ubiquitin
ligase candidates, we cotransfected the SNAIL-Luc gene with
individual E3 genes and examined the SNAIL-Luc protein stable
level. FBXO11 expression strongly reduced the stable SNAIL-
Luc protein level by up to 70% (Figures S2A and S2B). In a
CHX pulse-chase analysis of SNAIL-Luc, FBXO11 accelerated
SNAIL-Luc protein degradation, whereas SOCS3, SPSB1, and
TRIM5 had only modest or negligible effects on SNAIL-Luc pro-
tein degradation (Figure 2A; note that, in this and other similar
pulse-chase figures, Western blot images with different expo-
sure times were used so that the basal SNAIL-Luc protein
band intensity at time = 0 hr is the same across the experi-
mental group to illustrate the differences in the kinetics of
degradation).
To directly test the effect of FBXO11 on endogenous SNAIL
protein degradation, we generated FBXO11-overexpressing sta-
ble cell lines using SUM1315 and the LM2 subline of MDA-MB-
231 (Minn et al., 2005). In both cell lines, we observed a dramatic
increase of endogenous SNAIL protein degradation (Figures
S2C–S2F). Next we confirmed the interaction between endoge-
nous SNAIL and FBXO11 proteins by co-IP experiments using
MG132-treated LM2 cell lysate (Figure 2B). To further investigate
whether FBXO11 functions as a bona fide E3 ligase that ubiqui-
tylates the SNAIL protein, we cotransfected 293T cells with
SNAIL-FLAG, FBXO11, and HA-ubiquitin and treated the cells
with MG132 for 6 hr to prevent protein degradation before per-
forming an ubiquitylation assay. A significant increase of polyu-
biquitylated SNAIL protein was observed in FBXO11-transfected
cells, whereas an F-box (Skp1, Cullin, F-box [SCF] complex for-
mation domain) deletion mutant of FBXO11 (FBXO11-DF) was
not able to increase SNAIL ubiquitylation (Figure 2C).
Because SNAIL protein has been reported as a marker for a
poor prognosis, with its high expression correlated with worseFigure 1. A Genome-wide Functional Screen for E3 Ubiquitin Ligase(s)
(A) In SUM1315 cells, endogenous SNAIL protein was detected by Western blot a
hours. Western blot data are quantified in Figure S1A.
(B) Illustration of the dual luciferase reporter screening system for SNAIL-targetin
(C and D) CHX pulse-chase experiment demonstrating the degradation of SNAIL-
quantified in (D). Data are presented as mean ± SEM.
(E) The degradation of SNAIL-F-Luc protein was monitored by normalized lucifer
(F) Experimental procedure flow chart for identification of the E3 ubiquitin ligase(
(G) Luciferase-based siRNA library screen against human E3 ligases identified mu
increased luciferase activity more than 2-fold (top panel). A second round of siR
performed for confirmation of candidates.
(H and I) 293T cells were transfected according to the panel labels. The co-IP exp
ligase proteins (H) or an anti-FLAG antibody against SNAIL-FLAG protein (I).
See also Figure S1 and Tables S2 and S1.
Capatient outcome (Moody et al., 2005), we hypothesized that E3
ligase(s) targeting SNAIL should be a marker for a good prog-
nosis. Indeed, using the NKI295 breast cancer data set (van de
Vijver et al., 2002), we found that higher FBXO11 gene expres-
sion correlates significantly with longer metastasis-free survival
(Figure 2D), whereas SPSB1, SOCS3, and TRIM5 do not corre-
late with metastasis-free survival (Figure S2G).
To test the effect of reducing endogenous FBXO11 expression
on SNAIL protein degradation, we used siRNAs to knock down
FBXO11 gene expression in MCF10A cells. The stable level of
SNAIL protein was found to be upregulated more than 2-fold
after siRNA treatment (Figure 2E, left panel, without CHX treat-
ment). Furthermore, SNAIL protein was much more stable after
FBXO11 KD in a CHX pulse-chase assay (Figure 2E). Stabiliza-
tion of SNAIL after FBXO11 KD was also observed in the LM2
cell line (Figures S2H and S2I). Taken together, our results sug-
gest that SCF-FBXO11 is a bona fide E3 ubiquitin ligase targeting
SNAIL protein for ubiquitylation and degradation.
We confirmed that two previously reported E3s for SNAIL,
FBXW1 and FBXL14, also interact with SNAIL, whereas other
closely related F-box family members do not bind to SNAIL (Fig-
ures S2J–S2L). Interestingly, FBXW1 promoted SNAIL protein
degradation, whereas FBXL14 had no effect on SNAIL stability
(Figures S2M and S2N). Conversely, FBXW1 KD increased
SNAIL stability, whereas no effect was observed after FBXL14
KD. Importantly, simultaneous KD of FBXO11 and FBXW1 led
to increased SNAIL stabilization compared with either FBXO11
or FBXW1 KD alone (Figure 2E, right panel; Figures S2O and
S2P). These results suggest that both FBXO11 and FBXW1 are
capable of promoting SNAIL degradation and may function
collectively to control SNAIL stability.
FBXO11 Blocks SNAIL-Induced EMT and Tumorigenesis
SNAIL has been shown to induce EMT and increases the tumor-
initiating capability in nontransformed or oncogene-transformed
HMLE human mammary epithelial cells (Mani et al., 2008). We
testedwhether FBXO11 can block SNAIL-induced EMT by trans-
ducing Neu-transformed HMLEN cells with either SNAIL alone or
together with FBXO11. SNAIL expression induced strong EMT
phenotypes in HMLEN cells, with loss of E-CADHERIN and upre-
gulation of VIMENTIN and FIBRONECTIN (Figure 3A; Figures
S3A and S3B). When SNAIL and FBXO11 were coexpressed in
HMLEN cells, the stable level of SNAIL protein was decreased
significantly compared with cells only expressing SNAIL (Fig-
ure S3A). The reduced level of SNAIL led to the reversal of theTargeting SNAIL Protein for Degradation
nalysis after CHX (left panel) or MG132 treatment (right panel) for the indicated
g E3 ligases. CMV, cytomegalovirus; LTR, long terminal repeat.
F-Luc fusion protein in SUM-SNAIL-Luc/R-Luc cells (C). Western blot data are
ase activity measurement. Data are presented as mean ± SEM.
s) targeting SNAIL protein. See text for details.
ltiple E3 candidates that, when knocked down in SUM-SNAIL-Luc/R-Luc cells,
NA screening (bottom left panel) and immunoblotting (bottom right panel) was
eriment was performed using either an HA antibody to pull down HA-tagged E3
ncer Cell 26, 358–373, September 8, 2014 ª2014 Elsevier Inc. 361
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Figure 2. FBXO11 Is a Bona Fide E3 Ligase Targeting SNAIL Protein for Ubiquitination and Degradation
(A) Four E3 ligase candidates or a control pLEX-vector were cotransfected with the SNAIL-Luc plasmid into 293T cells, and a CHX pulse-chase assay was
performed. Western blot data were quantified using ImageJ software.
(B) LM2 cells were treated with 10 mMMG132 for 6 hr before the cell lysate was immunoprecipitated with FBXO11 antibody or an immunoglobulin G (IgG) control
and subjected to Western blot analysis.
(C) 293T cells were cotransfected with plasmids expressing HA-Ub and SNAIL-FLAG together with either a vector control, FBXO11, or the FBXO11-DF plasmid.
Cells were treated with MG132 for 6 hr before cell lysates were immunoprecipitated using a denature IP protocol to pull down SNAIL protein, and the poly-
ubiquitylated SNAIL protein was detected by anti-HA antibody.
(legend continued on next page)
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Figure 3. FBXO11 Blocks SNAIL-Induced EMT and Reduces Tumorigenesis Capability in HMLEN Cells
(A) Phase contrast and immunofluorescent (IF) images of HMLEN cells with stable overexpression of SNAIL or SNAIL together with FBXO11. Scale bar, 100 mm
(phase contrast images) and 25 mm (IF images).
(B) GSEA analysis of the environment of the EMT gene signature in HMLEN cells after overexpression of SNAIL with or without FBXO11.
(C) A heatmap was generated using hierarchical clustering of the microarray data for the indicated HMLEN cell lines. The 2,327 gene probes used for clustering
were those showing >2-folds expression changes upon SNAIL overexpression. The experiment was performed in duplicates.
(D) Boyden chamber invasion assay of HMLEN cells with SNAIL or SNAIL/FBXO11 overexpression. The data are shown as the mean of collected data from three
triplicate wells of three independent experiments. Data are presented as mean ± SEM. **p < 0.01, ***p < 0.001.
(E) Quantification of the colony formation assay results for the indicated HMLEN cell lines. Data are presented as mean ± SEM. **p < 0.01, ***p < 0.001.
(F and G) 2 3 104 of the indicated HMLEN cells were injected orthotopically into nude mice (n = 8), and primary mammary tumor growth was measured weekly
after injection (E). Representative tumor images are shown in (G). Data represent mean ± SD. **p < 0.01 by two-tailed Student’s t test.
See also Figure S3.
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at the cell-cell junctions and the loss of VIMENTIN and
FIBRONECTIN expression (Figure 3A; Figures S3A and S3B).
To evaluate the global transcriptomic changes associatedwith
expression of SNAIL and FBXO11, we performed gene expres-
sion microarray profiling and gene set enrichment analysis
(GSEA). Using four previously published EMT/cancer stem cell-
related gene signatures (see Supplemental Information), we
found that these signatures were enriched in SNAIL-overex-
pressing cells and that such an enrichment was lost in SNAIL/
FBXO11 cells (see Figure 3B using the Hennessy et al., 2009
Claudin-low/EMT signature as an example). We then generated(D) Kaplan-Meier plots of metastasis-free survival of patients stratified by express
breast cancer data set (van de Vijver et al., 2002).
(E) MCF10A cells were transfected with indicated siRNAs, followed by the CHX
See also Figure S2.
Caa gene expression heatmap using a list of 2,327 genes showing
>2-fold differential expression between the SNAIL-overexpress-
ing cells and the control cells. As shown in Figure 3C, FBXO11
expression largely reversed the gene expression changes
induced by SNAIL. Taken together, these results suggest that
FBXO11 can block the SNAIL-induced EMT program and asso-
ciated global gene expression pattern.
Because cells that undergo EMT often gain migratory and
invasive capabilities, we tested the Matrigel invasion ability
of these cells. As expected, SNAIL expression significantly in-
creased the invasiveness of HMLEN cells, whereas FBXO11
expression blocked SNAIL-induced invasion (Figure 3D). HMLEion of FBXO11. Data were obtained from the Netherlands Cancer Institute (NKI)
pulse-chase assay. Quantification data is shown in Figure S2P.
ncer Cell 26, 358–373, September 8, 2014 ª2014 Elsevier Inc. 363
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acquire breast cancer stem cell characteristics (Mani et al.,
2008). Indeed, HMLEN-SNAIL cells showed a significant in-
crease of the CD44high/CD24low population, whereas FBXO11
decreased this population (Figures S3C and S3D). In line with
the population shift, HMLEN-SNAIL showed increased colony
formation efficiency, whereas FBXO11 suppressed SNAIL-
induced colony formation (Figure 3E; Figure S3E). To further
test the effect of FBXO11 on tumor initiation, we injected
20,000 tumor cells orthotopically into the mammary fat pads of
nude mice. HMLEN cells had minimal tumor forming capability.
However, significant formation of primary tumors can be
observed 8 weeks after inoculation of SNAIL-overexpressing
HMLEN cells. Again, FBXO11 completely blocked SNAIL-
induced tumor initiation (Figures 3F and 3G). In aggregate, our
results demonstrate a prominent effect of FBXO11 in inhibiting
SNAIL-induced EMT and tumorigenesis in the HMLEN model,
and this effect is likely due to FBXO11-mediated ubiquitylation
and degradation of SNAIL protein.
FBXO11 Blocks SNAIL-Induced EMT and Lung
Metastasis In Vivo
To test the functional impact of FBXO11 on SNAIL-induced EMT
in breast cancer metastasis, we decided to use the epithelial-like
4T1 and EpRasmousemammary tumor cell lines, which are sen-
sitive to Snail-induced EMT and have much more robust primary
tumor growth capability than HMLEN. As expected, FBXO11
expression accelerated SNAIL degradation in 4T1 cells (Fig-
ure S4A). SNAIL overexpression in the epithelial-like 4T1 and
EpRas cell lines induced an EMT-like phenotype, including the
reduction of E-cadherin and upregulation of N-cadherin or Vi-
mentin expression at the both mRNA and protein levels (Figures
4A and 4B; Figures S4B–S4D). Strikingly, FBXO11 expression
blocked SNAIL-induced EMT in both cell lines. Gene expression
profiling revealed that the enrichment of EMT gene signatures
in SNAIL-overexpressing cells was reversed by FBXO11 over-
expression (Figure 4C). Likewise, overexpression of FBXO11
suppressed the SNAIL expression signature in 4T1 cells (Fig-
ure 4D). Consistent with cellular phenotype and gene expression
changes, the increased invasive capability of SNAIL-overex-
pressing 4T1 cells was inhibited by FBXO11 (Figure S4E). Impor-
tantly, although SNAIL overexpression did not affect primary
tumor growth when 105 tumor cells were injected orthotopically
(Figure S4F), its expression significantly increased spontaneous
lung metastasis in vivo (Figures 4E and 4F). The lung metastasis-
promoting effect of SNAIL was reversed after FBXO11 overex-
pression (Figures 4E and 4F), again without any significant alter-
ation in the primary tumor growth rate (Figures S4F and S4G).
To complement the findings obtained by using SNAIL and
FBXO11-overexpressing cells, we knocked down endogenous
Fbxo11 in 4T1 cells by short hairpin RNAs (Figure 5A). Western
blot analysis revealed a 5-fold upregulation of Snail protein after
stable knockdown of Fbxo11 (Figure 5B). Fbxo11 KD in 4T1 cells
induced EMT-like cellular changes, including reduction of E-cad-
herin and increase of Vimentin at the mRNA (Figure 5A) and
protein levels byWestern blot analysis and immunofluorescence
analyses (Figures 5B and 5C). Importantly, Fbxo11 KD signifi-
cantly increased lung metastasis (Figures 5D and 5E), despite
no difference in primary tumor growth (data not shown). Western364 Cancer Cell 26, 358–373, September 8, 2014 ª2014 Elsevier Incblot analysis of primary tumors confirmed that Snail expression
was upregulated and that E-cadherin expression was reduced
in Fbxo11 KD tumors (Figure S5A), consistent with an in vitro
analysis. Fbxo11 KD and Snail upregulation were also main-
tained in lung metastasis nodules (Figure S5B). These results
indicate that FBXO11 inhibits metastasis by promoting the ubiq-
uitylation and degradation of the EMT-inducing SNAIL protein.
Phosphorylation of Ser-11 on the SNAG Domain Is
Essential for SNAIL to Be Recognized by FBXO11
FBXO11 belongs to a large group of the F-box protein superfam-
ily. These proteins usually exert their E3 ligase function by forming
a four-subunit functional complex with Cullin, Skp, and Rbx pro-
teins (SCF complex), with F-box proteins as a substrate recogni-
tion component. Interestingly, F-Box proteins generally recognize
the protein substrate when they are phosphorylated (Cardozo
and Pagano, 2004). Therefore, it is plausible that SNAIL protein
also needs to be phosphorylated before being recognized by
FBXO11. To investigate this, we performed a modified co-IP
experiment in which cell lysate from 293T cells transfected with
SNAIL andFBXO11was treatedwith orwithout alkaline phospha-
tase (calf intestinal phosphatase [CIP]) to remove protein phos-
phorylation before IP. SNAIL was pulled down together with
FBXO11 protein, and this interaction was completely disrupted
by CIP treatment (Figure 6A), suggesting that phosphorylation
modification of either or both SNAIL and FBXO11might be critical
for the SNAIL-FBXO11 protein interaction. To identify the poten-
tial region within the SNAIL protein that is phosphorylated and
responsible for SNAIL-FBXO11 interaction, we generated several
SNAIL truncationmutations and performed the co-IP experiment.
Interestingly, only two truncation mutants, DSNAG and D194
(both lacking the first 20 amino acid SNAG domain on the SNAIL
protein) (Figure 6B), lost the ability to interact with FBXO11 (Fig-
ure 6C). Immunofluorescence analysis indicated that DSNAG
remained localized in the nucleus, suggesting that loss of interac-
tion between DSNAG and FBXO11 was not due to localization
change (Figure S7A). Therefore, the SNAG domain of SNAIL pro-
tein is critical for its interaction with FBXO11.
As recent literature suggests, there are at least five kinases
that phosphorylate SNAIL protein at distinct amino acids and
fine-tunes the functions of SNAIL differentially (Bastea et al.,
2012; Du et al., 2010; Eiseler et al., 2012; Pon et al., 2008;
Yang et al., 2005; Zhang et al., 2012a; Zhou et al., 2004). Phos-
phorylation of the Ser-11 site by protein kinase D1 (PKD1, also
known as PKCm) lies within the domain that we identified to be
responsible for SNAIL-FBXO11 interaction. Interestingly, aber-
rant upregulation of PKD1 has been suggested to block
SNAIL-induced EMT and anchorage-independent growth (Bas-
tea et al., 2012; Du et al., 2010; Eiseler et al., 2012). Therefore,
we tested whether the PKD1 consensus phosphorylation
sequence LXRXXS in the SNAG domain is essential for SNAIL-
FBXO11 interaction. We generated L6A-SNAIL, R8A-SNAIL,
and S11A-SNAIL alanine scanning mutants in the PKD1
consensus sequence and found that none of these mutants
could interact with FBXO11 anymore (Figures S6A and S6B).
Importantly, they also became stabilized compared with wild-
type SNAIL protein (Figure S6C). We further generated two addi-
tional mutants in Ser11, SNAIL-S11E and SNAIL-S11V, to mimic
and disrupt the phosphorylation of the SNAIL protein at Ser-11,.
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Figure 4. FBXO11 Blocked SNAIL-Induced EMT and Metastasis in the 4T1 Breast Cancer Cell Line
(A) Phase contrast and IF images for 4T1 cells transduced with the indicated lentiviruses. SNAIL induced a strong EMT program in 4T1 cells with downregulation
of E-cadherin and upregulation of N-cadherin expression, whereas FBXO11 blocked SNAIL-induced EMT. Scale bars, 25 mm.
(B) Quantitative RT-PCR (qRT-PCR) analysis of EMT marker mRNAs in the indicated 4T1 cell lines. Results were normalized to the GAPDH mRNA level. Data
represent mean ± SEM. *p < 0.05 by Student’s t test.
(C) A GSEA analysis demonstrated that FBXO11 expression inhibited the SNAIL-induced EMT gene signature in 4T1 cells.
(D) A heatmap was generated using hierarchical clustering. The 1,400 gene probes used for clustering were those showing >2-fold expression changes in SNAIL-
overexpressing cells.
(E) 105 cells were injected orthotopically into BALB/c mice (n = 10). The mice were sacrificed 3 weeks later. Representative lung metastasis nodule images are
presented.
(F) Numbers of lung metastasis lesions of mice injected with the indicated 4T1 cell lines. **p < 0.01 by Mann-Whitney U test.
See also Figure S4.
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completely lost the interaction with FBXO11 protein, whereas
the phosphorylation-mimicking mutant S11E still interacted
with FBXO11 (Figure 6D). Previous literature suggests that
GSK-3b-dependent phosphorylation on SNAIL protein is critical
for its recognition by FBXW1, another E3 ligase targeting SNAIL
protein (Zhou et al., 2004). We acquired several SNAIL mutants,
including the 6SA mutant, which can no longer be phosphory-
lated by GSK-3b, and performed a co-IP experiment with
FBXO11. Our results demonstrated that these mutants did notCadisrupt the interaction between SNAIL and FBXO11 protein (Fig-
ure S6D). Therefore, although both FBXO11 and FBXW1 can
destabilize SNAIL through UPS, distinct protein kinases are
involved in producing different phosphorylated SNAIL proteins
for recognition by these E3s.
To further test the effects of these mutations on SNAIL protein
degradation, we transfected these mutants either alone or
together with wild-type FBXO11 or FBXO11-DF expression vec-
tors into 293T cells and performed the CHX pulse-chase exper-
iment. In the absence of exogenous FBXO11, SNAIL-S11Encer Cell 26, 358–373, September 8, 2014 ª2014 Elsevier Inc. 365
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Figure 5. Knockdown of Endogenous FBXO11 Promotes Breast Cancer Metastasis
(A) Real-time PCR analysis of Fbxo11, Cdh1, and Vimentin expression in the parental and control 4T1 cell line and two Fbxo11-KD cell lines. Data represent
mean ± SD. **p < 0.01 by two-tailed Student’s t test.
(B) Western blot analysis of Snail, E-cadherin, and Vimentin expression in the indicated 4T1 cell lines.
(C) Phase contrast images and immunofluorescent images of EMT markers in the indicated 4T1 cell lines. Scale bars, 25 mm.
(D) 105 tumor cells from various 4T1 cell lines were injected orthotopically into BALB/c mice, and primary tumors were removed 10 days later. Lung metastasis
nodules were counted after sacrificing the mice at 38 days postinjection. **p < 0.01 by Mann-Whitney U test.
(E) Representative lung metastasis nodule images.
See also Figure S5.
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FBXO11 Inhibits EMT by Degrading SNAILdegraded much faster than wild-type (WT) SNAIL protein,
whereas SNAIL-S11V protein was stabilized (Figure 6E and
6F). In the presence of exogenous FBXO11, the stable level
of SNAIL protein was significantly lower than that of the S11V-
SNAIL mutant (Figure 6G). In the CHX pulse-chase experiment,
SNAIL protein turnover was accelerated by cotransfection with
FBXO11 but not the FBXO11-DF mutant lacking the SCF com-
plex formation domain. As expected, SNAIL-S11Vwasmore sta-
ble comparedwithwild-type SNAIL protein, even in the presence
of FBXO11 (Figures 6H and 6I). Taken together, our results sug-
gest that Ser-11 is the critical amino acid for SNAIL-FBXO11
interaction.
PKD1-Dependent Phosphorylation of Ser-11 Is Critical
for SNAIL Degradation
To directly test whether Ser-11 is phosphorylated by PKD1 in our
system, we cotransfected 293T cells with SNAIL-FLAG, HA-
FBXO11, and different wild-type or mutant PKD1 plasmids. In
one set of cell lysates, we first performed IP with an anti-FLAG
antibody to pull down SNAIL protein and examined the Ser-11
phosphorylation status by an antibody that specifically recog-
nizes p-Ser-11-SNAIL. SNAIL protein presented a very strong
phosphorylation band at the correct size, whereas PKD1 inhibi-
tor CID755673 treatment resulted in a loss of this phosphoryla-
tion band. PKD1 dominant-negative mutant (PKD1-KW), but
not thewild-type PKD1, also almost completely abolished SNAIL
protein phosphorylation (Figure 7A). In the remaining set of cell
lysates, we performed co-IP experiments with HA antibody to366 Cancer Cell 26, 358–373, September 8, 2014 ª2014 Elsevier Incpull down FBXO11 protein. The PKD1 inhibitor, as well as the
dominant-negative PKD1-KW mutant, disrupted the interaction
between SNAIL and FBXO11 protein (Figure 7B) and stabilized
SNAIL protein in the CHX pulse-chase experiment (Figure 7C;
Figure S7A) without changing the localization of SNAIL (Fig-
ure S7B). Consistent with these results, PKD1 inhibitor reduced
polyubiquitylated SNAIL protein bands compared with the con-
trol (Figure 7D). Importantly, both p-Ser-11-SNAIL and
FBXO11 localized in the nucleus, based on immunofluorescent
staining (Figure S7C), suggesting that PKD1-dependent target-
ing of SNAIL by FBXO11 may occur in the nucleus.
We further investigated the role of endogenous PKD1 in regu-
lating SNAIL protein stability. When we knocked down PKD1
expression by siRNAs (Figure S7D), we observed a significant
decrease in the Ser-11 phosphorylation level, loss of interaction
between SNAIL and FBXO11 (Figure 7E), and stabilization of the
endogenous SNAIL protein (Figure 7F; Figure S7E). Previous re-
ports demonstrated that RhoA is a physiological activator for
PKD1 kinase (Eiseler et al., 2009). Therefore, we used a constitu-
tively activated (CA) RhoA and a RhoA inhibitor, Exoenzyme C3
transferase protein (C3), to test their effects on SNAIL protein
degradation. We first confirmed the PKD1 activation status by
probing p-PKD1-744/748 in PKD1 pull-down samples (IP with
HA antibody) (Figure S7F). SNAIL and FBXO11 interaction was
also diminished significantly by the RhoA inhibitor (Figure S7G).
Consistently, SNAIL was stabilized after RhoA inhibition by C3,
whereas SNAIL degradation was accelerated in cells cotrans-
fected with the RhoA-CA mutant (Figure 7G; Figure S7H). Taken.
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Figure 6. Ser-11 in the SNAG Domain of SNAIL Is Responsible For Interaction with FBXO11
(A) 293T cells were transfected with SNAIL-FLAG and HA-FBXO11 for 2 days. Cell lysates were collected and treated either with or without CIP for 1 hr before
subjected to a co-IP experiment.
(B) Schematic of the SNAIL protein structure and the deletion mutation constructs generated to map out the interaction domain for SNAIL-FBXO11 interaction.
(C) Wild-type FLAG-tagged SNAIL and SNAIL truncation mutants were cotransfected with HA-FBXO11 into 293T cells, and cell lysates were collected for the co-
IP experiment using anti-FLAG antibody.
(D) Wild-type SNAIL and SNAIL-S11E and SNAIL-S11V single amino acid mutants were cotransfected with HA-FBXO11 into 293T cells, and cell lysates were
collected for the co-IP experiment using anti-HA antibody.
(E) CHX pulse-chase assay for wild-type SNAIL, SNAIL-S11E, and SNAIL-S11V in the absence of exogenously expressed FBXO11 in 293T cells. Data were
quantified using ImageJ software.
(F) Western blot images of the experiments in (E).
(G) 293T cells were transfected with the indicated expression plasmids, and cell lysates were collected for immunoblotting two days after transfection.
(H and I) 293T stable cells expressing corresponding wild-type SNAIL or mutant SNAIL were transfected with the indicated FBXO11 expression plasmids (H). A
pulse-chase assay was performed 2 days later. Data were quantified in (I) using ImageJ software.
See also Figure S6.
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by PKD1 at Ser-11, which promotes the interaction, ubiquityla-
tion, and degradation of SNAIL protein.
Previous results have demonstrated that WT SNAIL failed to
induce EMT inMCF7 cells, possibly because of its rapid turnover
rate and low stable protein level in this cell line (Zhou et al., 2004).
On the other hand, the SNAIL-6SA mutant, with disruption of the
GSK-3b phosphorylation sites (the binding site for FBXW1), was
able to induce EMT in MCF7 cells. Because the SNAIL-S11VCamutant disrupted the PKD1 phosphorylation site and also stabi-
lized SNAIL protein, we sought to determine whether the S11V
mutant is also able to induce EMT in MCF7 cells. Similar to
what has been reported before (Zhou et al., 2004), although
SNAIL failed to induce complete EMT in MCF7 cells, the 6SA
mutant induced strong EMT phenotypes in MCF7 cells (Fig-
ure 7H). The S11V mutant and the double S11V/6SA mutants
also induced a significant EMT program in MCF7 cells (Fig-
ure 7H). Immunofluorescent staining revealed a decrease ofncer Cell 26, 358–373, September 8, 2014 ª2014 Elsevier Inc. 367
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Figure 7. PKD1-Dependent Phosphorylation of SNAIL Ser-11 Is Critical for SNAIL Protein Degradation
(A) Detection of Ser11 phosphorylation of immunoprecipitated SNAIL protein when SNAIL was cotransfected with the indicated plasmids or treated with the
PKD1 inhibitor CID755673 in 293T cells. Cells were treated with MG132 for 6 hr before co-IP experiments.
(B) 293T cells were transfected or treated similarly as in (A) and then lysed, and a co-IP experiment was performed using anti-HA antibody. Cells were treated with
MG132 for 6 hr before co-IP experiments.
(legend continued on next page)
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FBXO11 Inhibits EMT by Degrading SNAILE-CADHERIN at the cell membrane and an increase of FIBRO
NECTIN in 6SA-, S11V-, and S11V/6SA-transduced MCF7 cells
but not in control or wild-type SNAIL-transduced MCF7 cells
(Figure 7H). Furthermore, although SNAIL was able to reduce
CDH1 expression and increase CDH2 and FN levels, these
changes were minimal compared with 6SA-, S11V-, and S11V/
6SA-induced changes. 6SA and S11V seem to have similar
effects on repression of CDH1 expression and induction of
CDH2/FN expression, whereas combining these two mutants
presented the strongest EMT phenotype, based on mRNA pro-
files (Figure 7I). To functionally test the effect of these mutants
on tumor invasion ability, we performed a Matrigel invasion
assay and revealed that the S11V-SNAIL and 6SA-SNAIL mu-
tants induced a much stronger invasive capability compared
with WT SNAIL or a vector control (Figure 7J). In aggregate,
our results demonstrate that PKD1 is responsible for phosphor-
ylation of Ser-11 on SNAIL protein and that this phosphorylation
promotes SNAIL protein ubiquitylation and degradation.
Negative Correlation of PKD1 and FBXO11with SNAIL in
Clinical Breast Cancer Samples
We used immunohistochemistry (IHC) staining to examine the
SNAIL protein expression level with the invasive property in
136 breast tumor samples collected at Sun Yat-Sen University
Cancer Center. Nuclear SNAIL protein expression correlates
positively with lymph node invasion (Figure 8A; Pearson c2 =
4.9, p = 0.026). Based on our finding that PKD1 phosphorylation
promotes SNAIL degradation, we next investigated the prog-
nosis value of PKD1. Consistent with its role in promoting SNAIL
protein degradation, a higher PKD1 expression level correlates
with longer relapse-free survival (Figure 8B; hazard ratio =
0.79, p < 0.001) in a large public clinical microarray database
of breast tumors from 1,354 patients (Gyo¨rffy et al., 2010).
Next, we tested the possible correlation between activated
PKD1 (pY95-PKD1 antibody staining) and p-Ser-11 SNAIL pro-
tein levels using a tissue microarray containing 100 breast can-
cer patient samples. Consistent with a previous report (Bastea
et al., 2012), activated PKD1 expression correlates positively
with p-Ser-11 SNAIL protein expression (Figures 8C and 8D;
c2 = 10.0, p = 0.0016). Finally, we tested the correlation between
FBXO11 and SNAIL expression in the same breast tumor sam-
ples and observed a strong negative correlation between(C) In 293T cells stably transfected with SNAIL, SNAIL protein turnover rates w
FBXO11 together with the indicated plasmids or the inhibitor CID755673. The W
(D) 293T cells were transfected with the indicated plasmids. Cells were treated wit
buffer. Cell lysates were subjected to denature IP with SNAIL antibody. Polyub
ubiquitin. Cells were treated with MG132 for 6 hr before co-IP experiments.
(E) MCF10A cells were treated with either 10 nM control or PKD1-targeting siRNA
antibodies. Cells were treated with MG132 for 6 hr before co-IP experiments.
(F) MCF10A cells were transfected with control or two PKD1 siRNAs. Two days
assay. The Western blot images in Figure S7E were quantified using ImageJ sof
(G) The 293T-SNAIL stable cell line was transfected with HA-PKD1 together with
chase assay was performed for SNAIL. The Western blot images in Figure S7H w
(H) Representative phase contrast images and immunofluorescent images of MC
E-cadherin; FN, Fibronectin.
(I) qRT-PCR was performed for CDH1, CDH2, VIM, and FN in the indicated MCF7
t test.
(J) Boyden chamber invasion assay of MCF7 cells stably expressing SNAIL or SN
t test. Vec, vector.
See also Figure S7.
CaFBXO11 and nuclear SNAIL expression because more than
70% of FBXO11-low samples have a high SNAIL level (Figures
8E and 8F; c2 = 7.49, p = 0.0062).
In conclusion, our study reveals a functionally important post-
translational control mechanism of the EMT master regulator
SNAIL. Our results suggest a model in which SNAIL protein is
phosphorylated by PKD1 kinase at the Ser-11 residue. Phos-
phorylated SNAIL protein is then recognized and polyubiquity-
lated by the SCF-FBXO11 E3 ligase complex for proteosomal
degradation, thereby limiting its ability to induce EMT, tumor initi-
ation, and metastasis (Figure 8G).
DISCUSSION
SNAIL is a conserved transcription factor that plays an essential
role in EMT during cancer metastasis. Recent discoveries also
revealed that SNAIL has a much broader effect on cancer pro-
gression, linking the SNAIL gene not only to EMT but also to
cancer stem cell properties (Mani et al., 2008), immune evasion
(Kudo-Saito et al., 2009), cancer metabolism (Dong et al.,
2013), and breast cancer relapse (Moody et al., 2005). Given
these important roles, a better understanding of the regulatory
mechanisms of the SNAIL protein level will provide additional
avenues to inhibit SNAIL-induced tumor malignancy in breast
cancer.
Previous results have demonstrated that SNAIL is a labile pro-
tein with a very short half-life (Zhou et al., 2004). Although E3 li-
gases often recognize their transcriptional factor substrates by
binding to their transcriptional regulatory domains, neither one
of the two previously identified E3 ligases for SNAIL, FBXW1/
b-TRCP, and FBXL14 interacts with the SNAG transcriptional
repression domain of SNAIL (Lander et al., 2011; Zhou et al.,
2004), leading us to suspect that there exist(s) additional E3 li-
gase(s) targeting the SNAG domain under the control of impor-
tant kinase signaling pathways. Conventionally, identifying
such E3 ligases is a time-consuming and often serendipitous
process. Proteomic analyses have been used to identify protein
substrates for certain E3 ligases (Emanuele et al., 2011). How-
ever, this method is not suitable to search for E3 ligases that
can degrade a specific protein substrate of interest. We devel-
oped a luciferase-based screening method to discover candi-
date E3 ligases for a specific protein substrate (SNAIL). It is worthere determined by CHX pulse-chase assays after cells were transfected with
estern blot images in Figure S8A were quantified using Image J software.
h DMSO or the PKD1 kinase inhibitor CID755673 before lysing in denature lysis
iquitylated SNAIL protein was visualized by HA antibody blotting against HA-
before being subjected to co-IP and Western blot analysis using the indicated
later, endogenous SNAIL degradation was determined by CHX pulse-chase
tware.
either vector or GST-tagged, constitutively active RhoA-CA, and a CHX pulse-
ere quantified using ImageJ software.
F7 cells stably expressing SNAIL or SNAIL mutants. Scale bars, 25 mm. E-CAD,
stable cell lines. Data represent mean ± SD. *p < 0.05 by two-tailed Student’s
AIL stabilization mutants. Data represent mean ± SD. **p < 0.01 by Student’s
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Figure 8. The SNAIL Protein Expression
Level Correlates Positively with Lymph
Node Invasion and Negatively with the
FBXO11 Expression Level in Breast Cancer
Patients
(A) Correlation study of the SNAIL expression level
with lymph node invasion in 136 breast tumor
specimens. SNAIL-lo, SNAIL IHC staining lower
than median; SNAIL-hi, SNAIL IHC staining higher
than median; LN, without lymph node invasion;
LN+, with lymph node invasion. c2 = 4.9, p = 0.026
by c2 test.
(B) Kaplan-Meier plots of distant relapse-free
survival of patients, stratified by expression of
PKD1. Data obtained from the Kaplan-Meier
plotter database (Gyo¨rffy et al., 2010).
(C) Correlation study of activated PKD1 (pY95-
PKD1) and S11-SNAIL in a breast tumor tissue
microarray (US Biomax BC081120). c2 = 10.0, p =
0.0016 by c2 test.
(D) Representative IHC images of pY95-PKD1 and
p-S11-SNAIL in breast tumors. Scale bars,
100 mm.
(E) Correlation study of SNAIL and FBXO11 in the
same breast tumor tissue microarray. c2 = 7.49,
p = 0.0062 by c2 test.
(F) Representative IHC images of SNAIL and
FBXO11 in breast tumors. Scale bars, 100 mm.
(G) Schematic of PKD1-dependent SNAIL protein
ubiquitylation and degradation by FBXO11. SNAIL
protein is first phosphorylated by PKD1 kinase
at Ser-11 before it can be recognized and ubiq-
uitylated by the SCF-FBXO11 E3 ligase com-
plex. Polyubiquitylated SNAIL protein is then
degraded through the 26S proteosomal degrada-
tion pathway.
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FBXO11 Inhibits EMT by Degrading SNAILnoting that other candidate SNAIL-targeting E3s identified in our
initial screen, including SOCS3, SPSB1, and TRIM5, can interact
directly with SNAIL and that the knockdown of these E3s
increased the steady-state level of SNAIL. However, overexpres-
sion of these three E3s did not accelerate SNAIL degradation. It
is possible that these E3s are already expressed at relative high
levels in 293T cells and that further overexpression of these
three E3 ligases will not further enhance their activity. The other
potential explanation is the off-target effect of siRNA knock-
down. For these reasons, we only consider an E3 as a true
candidate when it has strong effects on SNAIL protein degra-
dation in both knockdown and overexpression experiments.
Overall, our study serves as the proof of principle for adopting370 Cancer Cell 26, 358–373, September 8, 2014 ª2014 Elsevier Inc.such a screening and validation strategy
to effectively identify other E3 ligase-sub-
strate pairs.
Functionally, FBXO11 blocks SNAIL-
induced EMT in HMLEN cells, a
commonly used breast cancer EMT
model, by promoting SNAIL protein
degradation. Although HMLEN-SNAIL
cells become more mesenchymal-like
with enhanced tumor-initiating properties,
FBXO11 coexpression completely re-
verses these phenotypes. FBXO11 alsoprevents SNAIL-induced EMT and in vivo metastasis in the 4T1
and EpRas mammary tumor cell lines by ubiquitylating and de-
grading SNAIL protein. Knockdown of endogenous Fbxo11 also
stabilizes SNAIL protein, induces EMT in 4T1 cells, and promotes
lung metastasis. In line with its role as a negative regulator of the
prometastatic protein SNAIL, higher FBXO11 expression corre-
lates with longer metastasis-free survival in breast cancer pa-
tients. In our preliminary analysis, we did not find any correlation
of FBXO11 expression with the breast cancer subtype using the
publically available NKI295 data set, which has a limited sample
size. However, future studies using larger data sets are needed
to further analyze whether FBXO11 is correlated negatively with
the Claudin-low subtype, in which the gene expression signature
Cancer Cell
FBXO11 Inhibits EMT by Degrading SNAILof tumor samples resembles that of normal and cancerous stem
cells of the mammary gland.
Previouspublications identified five kinases that canphosphor-
ylate SNAIL protein. In our search, we found that PKD1-depen-
dent phosphorylation of Serine-11 on the SNAG domain is the
rate-limiting step for FBXO11-mediated SNAIL protein ubiquityla-
tionanddegradation.Mutationof theconsensusPKD1phosphor-
ylation site on SNAIL, particularly Ser-11, blocks its phosphoryla-
tion by PKD1 and disrupts the interaction of SNAIL with FBXO11.
Stabilized SNAIL-S11V protein promotes EMT in MCF7 breast
cancer cell lines, whereas the wild-type SNAIL fails to do so.
The SNAIL-FBXO11 complex is likely formed in the nucleus,
where both p-Ser-11-SNAIL and FBXO11 are detected. Although
p-Ser-11-SNAIL is most abundant in the nucleus, we cannot rule
out the possibility that PKD1-dependent phosphorylation can still
occur in the cytoplasm because many transcriptional factors are
shuttling constantly between the nucleus and the cytoplasm.
Our result is also consistent with previously established func-
tional role of PKD1 during EMT process. PKD1 has been reported
tomaintain the epithelial phenotype and inhibit EMTby phosphor-
ylation of SNAIL protein. PKD1 phosphorylates Ser-11 on SNAIL,
causing the repression of E-cadherin expression by triggering
SNAIL nuclear export (Du et al., 2010) or by forming an inactive
DNA/SNAI1 complex that shows decreased interaction with its
corepressor Ajuba (Bastea et al., 2012). Our findings demonstrate
that the phosphorylation at Ser-11 by PKD1 serves as another,
previously unknown distinct functional role in regulating SNAIL-
induced EMT and metastasis by promoting SNAIL protein ubi-
quitylation and degradation. Our analysis reveals that FBXO11
interacts with the PKD1-phosphorylated SNAG transcription
repressor domain, suggesting that FBXO11 is indeed an impor-
tant ‘‘classical’’ E3 ligase targeting SNAIL protein for degradation
by coupling the transcriptional activity with the degradation pro-
cess. Clinical sample analysis also confirms a positive correlation
of activated PKD1 and p-Ser-11 SNAIL expression. Importantly,
we also observed a strong negative correlation of SNAIL protein
and FBXO11 protein expression in breast cancer patients. In-
terestingly, it has been shown recently that the PKD1 level was
regulated at the epigenetic level (Borges et al., 2013). The PKD1
promoter is highly methylated, leading to a reduced PKD1 level
in metastatic breast cancer cells compared with nonmetastatic
breast cancer cells. This suggests a possible scenario in which
PKD1 silencing may lead to an increased level of SNAIL and a
subsequent increase in the metastatic ability of cancer cells.
During cancer progression, the ubiquitylation and deubiquity-
lation system has been shown, in recent years, to play critical
roles by aberrant signaling amplification (Zhang et al., 2012b),
promoting survival (Lau et al., 2012; Zhao et al., 2008), and
coping with DNA repair (Wu et al., 2012). Specifically, FBXO11
has also been identified to play multifaceted roles in cancer. In
human B cell lymphoma, SCF-FBXO11 targets BCL6, a
commonly overexpressed gene in aggressive diffuse large B
cell lymphoma (DLBCL), for ubiquitylation and proteosomal
degradation (Duan et al., 2012). Importantly, FBXO11 has been
found to be deleted or mutated in multiple DLBCL cell lines,
and inactivation of FBXO11 correlates with an increased level
of BCL6. These observations suggest that FBXO11 may be an
important tumor suppressor in DLBCL. More recently, SCF-
FBXO11 has been shown to interact with CDT2, a DCAF proteinCathat controls cell cycle progression, and to promote CDT2 pro-
teosomal degradation. This regulatory mechanism also has
important implications in cell cycle exit and cell migration (Abbas
et al., 2013; Duan et al., 2012). Our study extended the multifac-
eted role FBXO11 in cancer from a tumor suppressor to a key
metastasis inhibitor by suppressing SNAIL-mediated EMT, inva-
sion, and metastasis.
EXPERIMENTAL PROCEDURES
Animal Studies
All procedures involving mice and experimental protocols were approved by
Institutional Animal Care and Use Committee of Princeton University. For
orthotopic primary tumor formation, female BALB/c mice or athymic nude
mice 4-6 weeks of age were anesthetized, and a small incision was made to
reveal the mammary gland. Tumor cells suspended in 10 ml PBS were injected
directly into the mammary fat pad. The primary tumor growth was monitored
weekly by measurement of tumor size. In a 4T1 FBXO11-KD lung metastasis
assay, primary tumors were removed after 10 days. Lung metastasis nodes
were examined after euthanizing the mice at the experimental endpoint.
Clinical Data Set Analysis
NKI295 gene expression data were downloaded from the Stanford Microarray
Database. For E3 candidate survival analyses (FBXO11, SPSB1, and SOCS3),
distant metastasis-free survivals, stratified by expression of the gene of inter-
est, were presented as Kaplan-Meier plots and tested for significance using
log rank tests in the NKI295 data set. The TRIM5 gene was not included in
the NKI295 data set, and, therefore, it was analyzed using the online KMplot
database (http://www.KMplot.com) (Gyo¨rffy et al., 2010). A PKD1 survival
analysis was also done in the KMplot database using relapse-free survival.
Human Breast Cancer Tissue Microarrays
Formalin-fixed, paraffin-embedded microarrays of breast cancer tissues were
from US Biomax (BC081120) and from Sun Yat-Sen University Cancer Center.
Both sample sets used deidentified tumor samples and were considered
exempt by the institutional review boards of Princeton University and Sun
Yat-Sen University Cancer Center.
Statistical Analysis
Results were reported as mean ± SD or mean ± SEM as indicated in the figure
legends. Statistical comparisons were performed using unpaired two-sided
Student’s t test with unequal variance assumption. Statistical comparison
for the 4T1 lung metastasis assay was performed using Mann-Whitney
U test. Clinical correlation of SNAIL staining and lymph node invasion was per-
formed using a c2 test. Clinical correlation between SNAIL and FBXO11 or be-
tween pY95-PKD1 and p-Ser-11 SNAIL was also performed using a c2 test. All
experiments with representative images (including Western blot analysis and
immunofluorescence) were repeated at least twice, and representative images
are shown. The histology images in Figure 8 are representative of tumor spec-
imens of the same category (SNAIL-high or SNAIL-low).
ACCESSION NUMBERS
The raw and normalized microarray data have been deposited in the Gene
Expression Omnibus database under accession number GSE50889.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and two tables and can be found with this article online at
http://dx.doi.org/10.1016/j.ccr.2014.07.022.
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